FDCDDQ
ALXN

Federation des caisses Desjardins du Quebec’s Alexion Pharmaceuticals ALXN Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,207
Closed -$772K – 2653
2021
Q2 		$772K Sell
4,207
-3,120
-43% -$536K 0.01% 771
2021
Q1 		$1.12M Sell
7,327
-100,336
-93% -$15.5M 0.01% 655
2020
Q4 		$16.8M Buy
107,663
+16,311
+18% +$2.1M 0.2% 102
2020
Q3 		$10.5M Buy
91,352
+2,053
+2% +$221K 0.15% 138
2020
Q2 		$10M Buy
89,299
+2,909
+3% +$309K 0.15% 132
2020
Q1 		$7.76M Sell
86,390
-24
-0% -$2.35K 0.14% 132
2019
Q4 		$9.35M Buy
86,414
+1,350
+2% +$144K 0.13% 129
2019
Q3 		$8.33M Sell
85,064
-662
-0.8% -$74.6K 0.12% 147
2019
Q2 		$11.2M Sell
85,726
-33
-0% -$4.25K 0.17% 108
2019
Q1 		$11.6M Buy
85,759
+4,428
+5% +$551K 0.18% 102
2018
Q4 		$7.92M Sell
81,331
-1,219
-1% -$144K 0.13% 135
2018
Q3 		$11.5M Buy
82,550
+5,448
+7% +$683K 0.17% 110
2018
Q2 		$9.57M Buy
77,102
+77,000
+75,490% +$9M 0.14% 122
2018
Q1 		$11.4K Sell
102
-373
-79% -$44.6K ﹤0.01% 1682
2017
Q4 		$56.8K Buy
475
+25
+6% +$3.04K ﹤0.01% 1303
2017
Q3 		$63.1K Buy
450
+50
+13% +$6.79K ﹤0.01% 1263
2017
Q2 		$48.7K Buy
+400
New +$46.6K ﹤0.01% 1382

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ALXN Position: Q3 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,207 shares — an estimated $772K sold.

Federation des caisses Desjardins du Quebec first reported a position in ALXN in Q2 2017 and held it in 17 quarters. The position peaked at $16.8M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Federation des caisses Desjardins du Quebec reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 4,207 Alexion Pharmaceuticals shares in Q3 2021, an estimated $772K.
  • Federation des caisses Desjardins du Quebec first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 17 quarters.
  • Federation des caisses Desjardins du Quebec's Alexion Pharmaceuticals position peaked at $16.8M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2021, filed 30 Aug 2024.